Literature DB >> 6914196

The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.

E Holmer, K Kurachi, G Söderström.   

Abstract

Heparin fractions of different molecular weight and with high affinity for antithrombin were studied with respect to their ability to potentiate the inhibition of activated clotting factors by antithrombin. Inhibition of thrombin, Factor IXa and Factor XIa showed similarities in the dependence on the molecular weight of heparin and was found to decrease with decreasing molecular weight. Inactivation of Factor Xa, Factor XIIa and kallikrein was, however, less dependent on the size of the polysaccharide and, to a great extent, was potentiated even by low-molecular-weight heparin fractions that had virtually no effect on the inhibition of thrombin, Factor IXa and Factor XIa.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6914196      PMCID: PMC1162618          DOI: 10.1042/bj1930395

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Inhibition of bovine factor IXa and factor Xabeta by antithrombin III.

Authors:  K Kurachi; K Fujikawa; G Schmer; E W Davie
Journal:  Biochemistry       Date:  1976-01-27       Impact factor: 3.162

2.  The separation of active and inactive forms of heparin.

Authors:  L H Lam; J E Silbert; R D Rosenberg
Journal:  Biochem Biophys Res Commun       Date:  1976-03-22       Impact factor: 3.575

3.  Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin.

Authors:  M Höök; I Björk; J Hopwood; U Lindahl
Journal:  FEBS Lett       Date:  1976-07-01       Impact factor: 4.124

4.  The mechanism of activation of bovine factor IX (Christmas factor) by bovine factor XIa (activated plasma thromboplastin antecedent).

Authors:  K Fujikawa; M E Legaz; H Kato; E W Davie
Journal:  Biochemistry       Date:  1974-10-22       Impact factor: 3.162

5.  Isolation and characterization of bovine factor IX (Christmas factor).

Authors:  K Fujikawa; A R Thompson; M E Legaz; R G Meyer; E W Davie
Journal:  Biochemistry       Date:  1973-11-20       Impact factor: 3.162

6.  Bovine factor X 1 (Stuart factor). Mechanism of activation by protein from Russell's viper venom.

Authors:  K Fujikawa; M E Legaz; E W Davie
Journal:  Biochemistry       Date:  1972-12-19       Impact factor: 3.162

7.  Biological properties of the naturally occurring plasma inhibitor to activated factor X.

Authors:  E T Yin; S Wessler; P J Stoll
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

8.  Inhibition of activated factor XII by antithrombin-heparin cofactor.

Authors:  N Stead; A P Kaplan; R D Rosenberg
Journal:  J Biol Chem       Date:  1976-11-10       Impact factor: 5.157

9.  Evidence for the formation of an ester between thrombin and heparin cofactor.

Authors:  W G Owen
Journal:  Biochim Biophys Acta       Date:  1975-10-20

10.  The effect of antithrombin III on the activity of the coagulation factors VII, IX and X.

Authors:  B Osterud; M Miller-Andersson; U Abildgaard; H Prydz
Journal:  Thromb Haemost       Date:  1976-04-30       Impact factor: 5.249

View more
  34 in total

1.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin.

Authors:  B Bray; D A Lane; J M Freyssinet; G Pejler; U Lindahl
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

Review 2.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.

Authors:  P Andrade-Gordon; S Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Combinatorial one-pot chemoenzymatic synthesis of heparin.

Authors:  Ujjwal Bhaskar; Guoyun Li; Li Fu; Akihiro Onishi; Mathew Suflita; Jonathan S Dordick; Robert J Linhardt
Journal:  Carbohydr Polym       Date:  2014-11-07       Impact factor: 9.381

5.  Investigations on plasma activity of low molecular weight heparin after intravenous and oral administrations.

Authors:  M Dryjski; D E Schneider; P Mojaverian; B S Kuo; T D Bjornsson
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

6.  Visualizing correlated motion with HDBSCAN clustering.

Authors:  Ryan L Melvin; Jiajie Xiao; Ryan C Godwin; Kenneth S Berenhaut; Freddie R Salsbury
Journal:  Protein Sci       Date:  2017-09-06       Impact factor: 6.725

7.  The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.

Authors:  M Silverberg; S V Diehl
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

8.  The heparin-catalysed inhibition of human factor XIa by antithrombin III is dependent on the heparin type.

Authors:  H Soons; G Tans; H C Hemker
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

9.  Clinical efficacy of low molecular weight heparin in postoperative thrombosis prophylaxis.

Authors:  U Schmitz-Huebner; H Bünte; G Freise; B Reers; C Rüschemeyer; R Scherer; H Schulte; J van de Loo
Journal:  Klin Wochenschr       Date:  1984-04-16

10.  Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.

Authors:  D A Lane; J Denton; A M Flynn; L Thunberg; U Lindahl
Journal:  Biochem J       Date:  1984-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.